Consistent with these in vitro findings, analysis of the METABRIC dataset containing transcriptomic analyses of 1904 BC patients revealed significantly higher levels of TNF, RELA, RELB, IFNG, IRF1, and IL6 mRNA expression in ERα− tumors when compared to ERα+ ones (Fig. 3F). This evidence concerns the gene IRF1 and breast cancer.